131 related articles for article (PubMed ID: 9058644)
1. In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium.
Asahara H; Hasunuma T; Kobata T; Inoue H; Muller-Ladner U; Gay S; Sumida T; Nishioka K
J Rheumatol; 1997 Mar; 24(3):430-5. PubMed ID: 9058644
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis.
Hoa TT; Hasunuma T; Aono H; Masuko K; Kobata T; Yamamoto K; Sumida T; Nishioka K
J Rheumatol; 1996 Aug; 23(8):1332-7. PubMed ID: 8856610
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis in rheumatoid arthritis--expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues.
Chou CT; Yang JS; Lee MR
J Pathol; 2001 Jan; 193(1):110-6. PubMed ID: 11169523
[TBL] [Abstract][Full Text] [Related]
4. C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes.
Hashiramoto A; Sano H; Maekawa T; Kawahito Y; Kimura S; Kusaka Y; Wilder RL; Kato H; Kondo M; Nakajima H
Arthritis Rheum; 1999 May; 42(5):954-62. PubMed ID: 10323451
[TBL] [Abstract][Full Text] [Related]
5. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis.
Hashimoto H; Tanaka M; Suda T; Tomita T; Hayashida K; Takeuchi E; Kaneko M; Takano H; Nagata S; Ochi T
Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts.
Matsumoto S; Müller-Ladner U; Gay RE; Nishioka K; Gay S
J Rheumatol; 1996 Aug; 23(8):1345-52. PubMed ID: 8856612
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis.
Palao G; Santiago B; Galindo M; Payá M; Ramirez JC; Pablos JL
Arthritis Rheum; 2004 Sep; 50(9):2803-10. PubMed ID: 15457448
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells.
Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Sumida T; Nishioka K
Arthritis Rheum; 1999 Mar; 42(3):519-26. PubMed ID: 10088775
[TBL] [Abstract][Full Text] [Related]
10. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis.
Franz JK; Pap T; Hummel KM; Nawrath M; Aicher WK; Shigeyama Y; Müller-Ladner U; Gay RE; Gay S
Arthritis Rheum; 2000 Mar; 43(3):599-607. PubMed ID: 10728754
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer.
Okamoto K; Asahara H; Kobayashi T; Matsuno H; Hasunuma T; Kobata T; Sumida T; Nishioka K
Gene Ther; 1998 Mar; 5(3):331-8. PubMed ID: 9614552
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis.
Perlman H; Pagliari LJ; Liu H; Koch AE; Haines GK; Pope RM
Arthritis Rheum; 2001 Jan; 44(1):21-30. PubMed ID: 11212162
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of Fas antigen expression in synovial tissues from patients with rheumatoid arthritis.
Yu Q; Liu X; Shi G
Chin Med J (Engl); 1998 Mar; 111(3):211-3. PubMed ID: 10374417
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of conventional and real-time RT-PCR for the quantitation of jun protooncogene mRNA and analysis of junB mRNA expression in synovial membranes and isolated synovial fibroblasts from rheumatoid arthritis patients].
Huber R; Kunisch E; Glück B; Egerer R; Sickinger S; Kinne RW
Z Rheumatol; 2003 Aug; 62(4):378-89. PubMed ID: 12928942
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor of Fas-sensitive T cells in rheumatoid synovium.
Sumida T; Hoa TT; Asahara H; Hasunuma T; Nishioka K
J Immunol; 1997 Feb; 158(4):1965-70. PubMed ID: 9029139
[TBL] [Abstract][Full Text] [Related]
16. Expression of the precursor of secretoneurin, secretogranin II, in the synovium of patients with rheumatoid arthritis and osteoarthritis.
Sprott H; Pap T; Rethage J; Wintersberger W; Gay RE; Bradley LA; Uebelhart D; Gay S
J Rheumatol; 2000 Oct; 27(10):2347-50. PubMed ID: 11036828
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.
Ohshima S; Mima T; Sasai M; Nishioka K; Shimizu M; Murata N; Yoshikawa H; Nakanishi K; Suemura M; McCloskey RV; Kishimoto T; Saeki Y
Cytokine; 2000 Mar; 12(3):281-8. PubMed ID: 10704256
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
20. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]